Coronary heart disease in HIV-infected persons.
Treatment of HIV-infected patients with HAART has prolonged survival, and clinicians must now be concerned with chronic diseases, some of which may be more prevalent in this population. This article focuses on coronary heart disease in persons with HIV infection.
Glesby
Marshall J
MJ
Cornell Clinical Trials Unit, Weill Medical College of Cornell University, New York, USA.
D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000150:complications* / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015994:Incidence; D008297:Male; D010353:Patient Education as Topic
D008078:Cholesterol, LDL; D017320:HIV Protease Inhibitors; D000960:Hypolipidemic Agents